Development of subtype selective GABAA modulators

scientific article

Development of subtype selective GABAA modulators is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P698PubMed publication ID15618944

P2093author name stringGerard R Dawson
John R Atack
Neil Collinson
P433issue1
P304page(s)21-27
P577publication date2005-01-01
P1433published inC N S SpectrumsQ15750260
P1476titleDevelopment of subtype selective GABAA modulators
P478volume10

Reverse relations

cites work (P2860)
Q39456055A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain.
Q24644809Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond
Q90463024Amino acid substitutions in the human homomeric β3 GABAA receptor that enable activation by GABA
Q26865012Application of cross-species PET imaging to assess neurotransmitter release in brain
Q36054271Differential interactions engendered by benzodiazepine and neuroactive steroid combinations on schedule-controlled responding in rats
Q42669837Insights into functional pharmacology of α₁ GABA(A) receptors: how much does partial activation at the benzodiazepine site matter?
Q28540055Mass spectrometric detection and characterization of atypical membrane-bound zinc-sensitive phosphatases modulating GABAA receptors
Q34768548Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023
Q35658253Positional clustering improves computational binding site detection and identifies novel cis-regulatory sites in mammalian GABAA receptor subunit genes
Q33574884Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes

Search more.